Immune cell therapy for advanced liver cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests a new treatment using your own immune cells (tumor-infiltrating lymphocytes) to fight advanced liver cancer. It is for people whose cancer has progressed after at least two standard treatments and who have tumors that can be biopsied to grow these cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced liver cancer that has been confirmed by biopsy.
- Your cancer has gotten worse after at least two standard treatments, and no other treatments are available.
- You have at least one tumor that can be safely biopsied to obtain tissue, and at least three metastatic tumors visible on scans.
- You are between 18 and 70 years old and have a good physical condition (ECOG score 0 or 1).
- Your liver is working well (Child-Pugh score A) and your blood counts, kidney, and liver tests are within specific limits.
- You cannot have active hepatitis B or C, HIV, serious heart problems, or uncontrolled autoimmune diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests engineered immune cells (TILs/CAR-TILs) made from your tumor to treat advanced solid cancers that have not responded to standard treatments. It may help your immune system better recognize and attack the cancer, but it is mainly focused on safety and early results.
This trial studies a treatment called TIL therapy, which uses your own immune cells grown from a tumor sample, to treat advanced cancers of the liver/bile ducts or pancreas. It’s mainly for people whose standard treatments have already failed (or none exist), and who can safely provide tumor tissue for the cell preparation.
This trial tests a new therapy made from your own immune cells (called TILs). The cells are taken from your tumor, multiplied in a lab, and given back to you to help your body fight the cancer. It's an early study to see if it's safe and if it can shrink liver cancer.
This trial tests a new immune cell therapy for people with advanced solid tumors (lung, liver, colorectal, or breast cancer). It aims to use your own immune cells to fight the cancer, and might help if standard treatments have stopped working.
This trial tests a personalized treatment using your own immune cells (called TILs) to fight advanced non-small cell lung cancer that has progressed after standard therapy. You would have surgery to collect a tumor sample, then receive your expanded immune cells back as an infusion.
This trial tests a treatment made from your own immune cells (called tumor-infiltrating lymphocytes). The cells are taken from a tumor sample, multiplied in a lab, and given back to you to help fight the cancer. It's for people with melanoma that has not responded to standard immunotherapy.
Hear when a new Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.